MAUDE Adverse Event Report: BIOMET 3I T3® PRO NON-PLATFORM SWITCHED TAPERED IMPLANT 3.25MM (D) X 15MM (L); DENTAL IMPLANT

Catalog Number	T3ST3215
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Osteolysis (2377); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	08/05/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Zimvie complaint number (b)(4).The following fields have been updated: b4: date of this report, b5: describe event or problem, g3: date received by manufacturer, g6: type of report, h1: type of reportable event, h2: follow up type, h3: device evaluated by manufacturer, h6: adverse event problem, h10: additional narrative.Zimvie received one (1) t3st3215, (t3® pro non-platform switched tapered implant 3.25mm (d) x 15mm (l) for evaluation.Visual evaluation was performed; the implant has signs of use with debris on its external threads.There was no damage identified or signs of malfunction that would have contributed to the event.Measurements match drawing.Dhr review was completed for the subject lot number 2120014104.No deviations or non-conformances, which could have caused or contributed to the reported event, were noted as part of the dhr.Complaint history review was performed for the reported lot number 2120014104 for similar events and no other complaint was identified.Review completed utilizing keywords: ¿dental: medical: bone loss and dental: medical: other¿ based on the investigation and risk management file review, the most likely root cause determined from the investigation was inadequate treatment planning and patient factors.Therefore, based on the available information, a device malfunction did not occur.No damage to the implant was identified.The reported event was non-verifiable.Bone loss is a medical condition and is non-verifiable with all available information.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the products were nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.Similar complaints for bone loss related problems have been previously investigated.Refer to attached summary investigation.Visual and dimensional evaluations of the previously returned product have not identified or suggested manufacturing non-conformances.Furthermore, the probability of manufacturing or design defects that might lead to bone loss escaping the available detections is remote and almost nonexistent.Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming product.Additionally, all device history record reviews verified that each implant was sterilized per procedure for every device.All complaint data used for the summary investigation was found to be conforming and did not meet capa/hhe/d/ or any further escalations.Therefore, there were no complaints which confirmed a manufacturing or design related issue that did or could cause or contribute to the reported event.At this time, the complaint investigation has been completed and the record will be closed.If additional information is received, the record will be re-opened for further evaluation.
Event or Problem Description
It was reported that the implant at tooth site #10 was removed due to bone loss.(b)(6) 2025 #10 12mm probing depths on the distal & 10mm probing depth on the mesial.There is evidence of bone loss along the axial surface of the implant.Integrated implant at site #10 with vertical bone loss.(b)(6) 2025 #10 healing abutment was removed.Implant was removed using reverse torque.A full thickness flap was reflected.There was 6mm dehiscence of buccal bone noted.All other bony walls remained intact.The osteotomy was debrided of all soft tissue down to healthy bone.Co/caxa regeneross bone mixed with prf exudate was used to graft the osteotomy & buccal defect.A prf was placed over the site.Soft tissue were re approximated using 3-0 gut suture.Was the procedure completed using another implant or another device: no, only grafting was completed.Patient will return for implant placement.Additional appointment required: yes, only grafting was completed.Patient will return for implant placement.
Event or Problem Description
It was reported that the implant at tooth site #10 was removed due to bone loss.A full thickness flap was reflected.There was 6mm dehiscence of buccal bone noted.All other bony walls remained intact.The osteotomy was debrided of all soft tissue down to healthy bone.
Additional Manufacturer Narrative
Zimvie complaint number (b)(4).A1: patient identifier unknown / not provided.A2: age and date of birth unknown / not provided.A3: patient sex unknown / not provided.A4: weight unknown / not provided.Product has been received by zimvie and the investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.

• Brand Name: T3® PRO NON-PLATFORM SWITCHED TAPERED IMPLANT 3.25MM (D) X 15MM (L)
• Common Device Name: DENTAL IMPLANT
• Manufacturer (Section D): BIOMET 3I; 4555 riverside drive; palm beach gardens FL 33410
• Manufacturer (Section G): BIOMET 3I; 4555 riverside drive; palm beach gardens FL 33410
• Manufacturer Contact: carlos gordian-arroyo ; 4555 riverside drive; palm beach gardens, FL 33410 ; 5619713230
• MDR Report Key: 23061618
• Report Number: 0001038806-2025-02167
• Device Sequence Number: 15873321
• Product Code: DZE
• UDI-Device Identifier: 00844868046899
• UDI-Public: (01)00844868046899(17)290526(10)2120014104
• Combination Product (Y/N): N
• Initial Reporter State: IA
• Initial Reporter Country: US
• PMA/510(K) Number: K213672
• Exemption Number: 5645646
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Device Explanted Year: 2025
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 12/09/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Other
• Device Catalogue Number: T3ST3215
• Device Lot Number: 2120014104
• Was Device Available for Evaluation?: No
• Date Returned to Manufacturer: 08/26/2025
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: Not provided
• Supplement Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 09/16/2025
• Supplement Report FDA Received Date: 12/09/2025
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 05/27/2024
• Is the Device Labeled for Single Use? (Y/N): No
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Unknown
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Unknown
• Patient Ethnicity: Non Hispanic